Gamida Cell For Profit

Gamida Cell is a company that specializes in cell and immune therapy technologies. They aim to provide potentially curative cell therapies to patients with cancer. The company uses proprietary nicotinamide (NAM) technology to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic malignancies. Gamida Cell has a dedicated team of pioneers with respected track records in cell therapy research and development, manufacturing and commercialization. They put the needs and experiences of patients at the core of their mission and purpose. Contact_info: No contact information provided on the main page.

Headquarters: Jerusalem, Yerushalayim, Israel
Last Funding Type: Post-IPO Debt
Investors Number: 14
Last Funding Date: 16.02.2021
Employee Number: 101-250
Total Funding: 267 753 823
Founded Date: 1998-01-01
Technology: Drug development
Estimated Revenue: $10M to $50M
Industry: PharmTech
Funding Status: IPO